
Please try another search
Takara Bio Inc., together with its subsidiaries, engages in the businesses of reagents, equipment, contract services, and genetic medicine in Japan, China, the rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including reagents needed for genetic and cellular research, PCR instruments, cellular analysis devices, and in vitro diagnostics for COVID-19 testing. It also provides contract services related to regenerative medicine products and contract services related to gene analysis and testing. In addition, the company is involved in commercialization of its proprietary platform technology for biologics development; development, manufacture, and sale of manufacture ancillary materials, such as RetroNectin that is used in the manufacture of gene therapy product; application for marketing authorization of NY-ESO-1 siTCR gene therapy product; and development of JAK/STAT technology suitable for CAR gene therapy and applied development of CereAAV™, a brain-tropic adeno-associated virus vector. It provides its products and services through sales agents or directly to its customers. The company was incorporated in 2002 and is headquartered in Kusatsu, Japan. Takara Bio Inc. is a subsidiary of Takara Holdings Inc.
Name | Age | Since | Title |
---|---|---|---|
Takuya Kakemi | - | 2023 | Audit & Supervisory Board Member |
Tsuyoshi Miyamura | 62 | 2014 | President, CEO & Director |
Koichi Nakao | 63 | 2002 | Chairman |
Mutsumi Kimura | 62 | 2006 | Director |
Yoh Hamaoka | 63 | 2021 | CFO, Senior Executive Officer & Director |
Masaaki Makikawa | 73 | 2017 | Independent Outside Audit & Supervisory Board Member |
Yasuo Himeiwa | 72 | 2016 | Independent Outside Audit & Supervisory Board Member |
Nobuko Kawashima | 63 | 2016 | Independent External Director |
Noriomi Matsumura | 54 | 2020 | Independent External Director |
Junichi Mineno | 65 | 2011 | VP, Executive Officer & Director |
Katsuhiko Kusakabe | 64 | 2017 | CMCO, Executive Officer & Director |
Satoshi Kumo | 59 | 2025 | Audit & Supervisory Board Member |
Kunihiko Kamada | 65 | 2016 | Independent Outside Audit & Supervisory Board Member |
Kazuko Kimura | 74 | 2019 | Independent External Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review